SOPHiA GENETICS SA·4

Mar 20, 4:01 PM ET

Valente Manuela 4

Research Summary

AI-generated summary

Updated

SOPHiA GENETICS (SOPH) CPO Manuela Valente Sells 380 Shares

What Happened

  • Manuela Valente, Chief People Officer of SOPHiA GENETICS SA (SOPH), sold 380 shares in an open-market transaction on March 19, 2026.
  • The reported weighted-average price was $4.79 per share, resulting in proceeds of approximately $1,818. The sales were executed to satisfy tax obligations arising from the March 18, 2026 vesting of restricted stock units (RSUs).

Key Details

  • Transaction date: 2026-03-19 (reported on Form 4 filed 2026-03-20).
  • Shares sold: 380; weighted-average price: $4.79; total proceeds: ~$1,818.
  • Price range: $4.68–$4.87 (multiple executions; the filer can provide a breakdown on request).
  • Reason/footnotes: Sale effected to satisfy tax withholding on RSU vesting; executed under a pre-established Rule 10b5-1 trading plan and not discretionary (Footnote F1).
  • Transaction code: S (Sale).
  • Shares owned after transaction: not reported in the provided filing details.
  • Filing timeliness: Reported the next day (timely under Form 4 reporting rules).

Context

  • This was a routine sale to cover tax withholding on vested RSUs and was executed under a pre-set 10b5-1 plan. Such transactions are common and do not necessarily indicate the insider’s view on the company’s prospects. Purchases by insiders tend to be more informative about insider sentiment.